We are pleased to announce the availability of First Trimester Prenatal Screening. This major new innovation in screening called Early Screen involves the combination of a dried blood free Beta/PAPP-A laboratory test with an Ultrasound nuchal translucency measurement assessment. Nuchal Translucency/free Beta/PAPP-A is an option for all pregnant women. Early Screen detects chromosomal, heart (40%), and other fetal anomalies and perinatal risks. Our Ultrasound technician has received an NT certificate from the Fetal Medicine Foundation in London England. Patients  may be referred for Early Screen evaluation between CRL 45 to 84mm which is 11w1d and 13w6d gestation. Our goal is to provide our patients the most advanced and accurate perinatal and genetic personalized care.
_______________

New Halo Breast Pap Test Offered
Click here for News-Gazette article

Women's Health Practice is the first in Illinois to offer a new noninvasive Halo Breast Pap Test that may identify breast disease years earlier than a mammogram or self exam. Click here for more info

Keep an eye out for the Halo Breast Pap Test TV commercials.